Page 118 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 118
EASL Premium Sponsors support all EASL activities and programmes throughout the
year providing funding for Schools of Hepatology, Fellowships, Bursaries, Monothematic
Conferences, Special Conferences, Webcasting and the EASL EU Framework.
WHY WE SUPPORT EASL...
As a global, research-based biopharmaceutical We are a global biopharmaceutical company
company, our mission is to develop and market whose mission is to discover, develop
advanced therapies that address some of the and deliver innovative medicines. We
world’s most complex and serious diseases, are committed to Helping Advance the
including liver disease. Management of Liver Disease.
Gilead Sciences discovers and develops
innovative medicines in areas of unmet
need. Aiming to improve patient care in
life-threatening diseases, our commitment
includes over a decade of liver disease
research.
www.easl.eu/premium-sponsors
year providing funding for Schools of Hepatology, Fellowships, Bursaries, Monothematic
Conferences, Special Conferences, Webcasting and the EASL EU Framework.
WHY WE SUPPORT EASL...
As a global, research-based biopharmaceutical We are a global biopharmaceutical company
company, our mission is to develop and market whose mission is to discover, develop
advanced therapies that address some of the and deliver innovative medicines. We
world’s most complex and serious diseases, are committed to Helping Advance the
including liver disease. Management of Liver Disease.
Gilead Sciences discovers and develops
innovative medicines in areas of unmet
need. Aiming to improve patient care in
life-threatening diseases, our commitment
includes over a decade of liver disease
research.
www.easl.eu/premium-sponsors
